Liposomal Formulation Makes Medication Delivery Safer And More Effective

By Mayra Pierce


Nanotechnology refers to the manipulation of substances on the atomic and molecular level. Liposomes are small encapsulating bubbles that are microscopic in size, made of materials called phospholipids that mimic human cells, and have the property of being both attracted and repelled by water. Liposomal formulation includes the process that forms those bubbles, as well the encapsulation and delivery of the drugs contained within.

The significance of these vesicular containers containing soluble molecules first became apparent soon after they appeared during the 1960s. Pharmacists as well as researchers recognized their potential for safely and slowly administering specific pharmaceuticals important to treating cancer and other illnesses. The new method could target undesirable cells more efficiently, and had fewer side issues associated with some medications.

The concept they use is radically different because it does not depend of standard modes of absorption typical of IV or oral administration. Conventional chemical processes can make management of specialized drugs more difficult. They are indiscriminate in their toxicity, and affect healthy organs as well, resulting in unnecessary damage and more lengthy recovery. When delivered via liposomes, release of toxic medication can be better controlled.

The molecules of a drug are suspended in water within the structure of the artificial cell, which is surrounded by a manufactured membrane. The formulating process of specifically designed liposomes transforms them into mechanisms ideal for transporting hydrophilic drugs, or those that are attracted to water and dissolve effectively. Current methods produce two primary forms called unilammelar and multilammelar, and subcategories include varying sizes.

Molecules of a particular drug are encased within a membrane, and can be transferred to the targeted cells upon activation. They can be effectively released into an organism by fusing specific layers with other living cells, which delivers the tiny doses they contain. Other methods of release use reactive chemicals that also encourage diffusion at the molecular level. The overall result is a more controllable, steady release.

This not only creates medicines that are more easily administered and managed, but does so in a bio-compatible way that leaves little toxic residue in non-targeted organs. Relatively recent developments involve the use of ultrasound to trigger release in specific locations where they are necessary. Other delivery methods include using the respiratory system, especially the lungs, where they can be activated slowly, reducing unwanted toxicity.

It is still costly to manufacture these microscopic capsules for medical use. As continuing research produces a growing number of uses for this kind of nanotechnology, the overall expense will decline, but will not become cheap. Because this is relatively new technology in many ways, there are issues that still must be resolved. Some types of structures have experienced cellular leaking, and others have been affected by oxidation.

Like some other medical innovations, liposomes are now being introduced into consumer products. They are currently promoted as a beneficial way to administer herbal, vitamin and mineral supplements, and some individuals have created their own unique formulations. Although commercial applications produce controversy regarding efficacy, the continued development of new processes provides the basis for more effective medical uses.




About the Author:



No comments:

Post a Comment